The New Structures of Platform Deals
This article was originally published in Start Up
Executive Summary
Platform deals are still occurring, but thanks to the changing economics of the pharmaceutical industry, particularly drug companies' infatuation with late-stage deals, platform deal structures are changing. Dollar values are generally lower; tech transfer is more common; royalties and product-based milestones rarer.